Anavex Life Sciences Corp. (AVXL) DCF Valuation

Anavex Life Sciences Corp. (AVXL) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Anavex Life Sciences Corp. (AVXL) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify Anavex Life Sciences Corp. (AVXL) valuation with this customizable DCF Calculator! Featuring real Anavex Life Sciences Corp. (AVXL) financials and adjustable forecast inputs, you can test scenarios and uncover Anavex Life Sciences Corp. (AVXL) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA .0 .0 -50.9 -55.8 .0 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 26.7 37.5 -3.3 -2.7 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -26.7 -37.5 -47.6 -53.0 .0 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 29.2 152.1 149.2 151.0 132.2 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 4.8 9.1 3.2 2.7 2.4
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 4.0 4.7 3.8 4.3 9.6 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -26.7 -37.7 -48.0 -53.0 .0 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -.9 -3.8 -46.3 -54.8 5.6 -7.2 .0 .0 .0 .0
WACC, % 7.3 7.3 7.3 7.3 7.3 7.3 7.3 7.3 7.3 7.3
PV UFCF
SUM PV UFCF -6.7
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -7
Net Debt -132
Equity Value 125
Diluted Shares Outstanding, MM 83
Equity Value Per Share 1.50

What You Will Get

  • Real AVXL Financial Data: Pre-filled with Anavex Life Sciences Corp.’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Anavex Life Sciences Corp.’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Comprehensive Anavex Financials: Gain access to precise historical data and future forecasts tailored for Anavex Life Sciences Corp. (AVXL).
  • Tailorable Projection Assumptions: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
  • Real-Time Calculations: Automatic adjustments to DCF, Net Present Value (NPV), and cash flow metrics.
  • User-Friendly Dashboard: Clear and concise charts and summaries for effective visualization of your valuation outcomes.
  • Designed for All Experience Levels: An intuitive layout suitable for investors, CFOs, and consultants alike.

How It Works

  • Download: Obtain the pre-configured Excel file containing Anavex Life Sciences Corp.'s (AVXL) financial data.
  • Customize: Modify forecasts, such as revenue growth, EBITDA %, and WACC to fit your analysis.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time as you make adjustments.
  • Test Scenarios: Generate various projections and evaluate outcomes without delay.
  • Make Decisions: Leverage the valuation results to inform your investment choices.

Why Choose This Calculator for Anavex Life Sciences Corp. (AVXL)?

  • Accurate Data: Real Anavex financials ensure reliable valuation results.
  • Customizable: Adjust key parameters like growth rates, WACC, and tax rates to align with your projections.
  • Time-Saving: Pre-built calculations save you from starting from scratch.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Intuitive design and step-by-step guidance make it accessible for all users.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and trustworthy valuation models for analyzing portfolios involving Anavex Life Sciences Corp. (AVXL).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Deliver precise valuation insights for clients interested in Anavex Life Sciences Corp. (AVXL).
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling related to biotech companies.
  • Biotech Enthusiasts: Gain insights into how biotech firms like Anavex Life Sciences Corp. (AVXL) are assessed in the market.

What the Template Contains

  • Pre-Filled DCF Model: Anavex Life Sciences Corp.'s (AVXL) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Anavex Life Sciences Corp.'s (AVXL) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.